This revealed a significantly lower expression of the FoxO target genes Calatase and MNSOD in AML patients with a favorable prognosis (Figure 5B), while high expression of MNSOD was associated with a worse overall survival (Figure 5C). This evidence concerns the gene SOD2 and acute myeloid leukemia.